News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,748 Results
Type
Article (40079)
Company Profile (271)
Press Release (661398)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (205093)
Career Advice (2020)
Deals (35534)
Drug Delivery (97)
Drug Development (81240)
Employer Resources (172)
FDA (16210)
Job Trends (14914)
News (346465)
Policy (32651)
Tag
Academia (2573)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49777)
ALS (88)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (127)
Approvals (16215)
Artificial intelligence (255)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (190)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (279)
Cancer (2265)
Cardiovascular disease (174)
Career advice (1688)
Career pathing (30)
CAR-T (153)
Cell therapy (429)
Cervical cancer (19)
Clinical research (66114)
Collaboration (841)
Company closure (1)
Compensation (533)
Complete response letters (19)
COVID-19 (2604)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (20)
Depression (43)
Diabetes (271)
Diagnostics (6390)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86766)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112924)
Executive appointments (729)
FDA (17476)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (19)
Gene therapy (303)
GLP-1 (713)
Government (4432)
Grass and pollen (4)
Guidances (67)
Healthcare (18834)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (141)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16543)
IRA (42)
Job creations (3665)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (475)
Leadership (17)
Legal (7944)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13388)
Medtech (13393)
Mergers & acquisitions (19535)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1922)
NextGen: Class of 2025 (6548)
Non-profit (4491)
Now hiring (39)
Obesity (364)
Opinion (208)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57634)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20616)
Phase II (29120)
Phase III (21681)
Pipeline (1203)
Policy (142)
Postmarket research (2564)
Preclinical (8772)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5953)
Recruiting (65)
Regulatory (22351)
Reports (46)
Research institute (2328)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (133)
Series B (84)
Service/supplier (13)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3629)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (30)
Vaccines (691)
Venture capitalists (43)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (50)
Last 7 days (903)
Last 30 days (2592)
Last 365 days (32790)
2025 (10780)
2024 (35330)
2023 (40179)
2022 (51287)
2021 (55837)
2020 (54154)
2019 (46644)
2018 (35125)
2017 (32222)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27526)
Location
Africa (721)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38050)
Australia (6232)
California (6158)
Canada (2018)
China (524)
Colorado (268)
Connecticut (274)
Delaware (148)
Europe (81757)
Florida (912)
Georgia (206)
Idaho (58)
Illinois (539)
India (26)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4584)
Michigan (220)
Minnesota (391)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (64)
New Jersey (1729)
New Mexico (28)
New York (1747)
North Carolina (968)
North Dakota (8)
Northern California (2688)
Ohio (206)
Oklahoma (14)
Oregon (35)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (23)
South Dakota (1)
Southern California (2314)
Tennessee (101)
Texas (912)
United States (23196)
Utah (180)
Virginia (147)
Washington D.C. (63)
Washington State (555)
West Virginia (3)
Wisconsin (54)
701,748 Results for "arcadia biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call
April 30, 2025
·
1 min read
Lone Star Bio
Arcadia Biosciences (RKDA) To Host Investor Call To Discuss Recent Transactions
Arcadia Biosciences, Inc. today announced that it will host a call for analysts and investors after market close on May 22, 2024.
May 17, 2024
·
1 min read
Lone Star Bio
Arcadia Biosciences (RKDA) Announces Sale of GoodWheatTM to Above Food Corp.
Arcadia Biosciences (RKDA) Announces Sale of GoodWheat TM to Above Food Corp.
May 16, 2024
·
4 min read
Business
Arcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)
Arcadia Biosciences, Inc. announced today it has sold its non-GMO Resistant Starch (RS) Durum Wheat trait to longtime partner Corteva Agriscience.
May 14, 2024
·
2 min read
Business
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call
Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the fourth quarter and full year of 2023 after market close on March 28, 2024.
March 14, 2024
·
1 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Business
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2023 Financial Results and Business Highlights Conference Call
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2023 after market close on August 10, 2023.
July 27, 2023
·
1 min read
1 of 70,175
Next
